NCT07607678
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07607678
Title A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Yale Cancer Center NOT_YET_RECRUITING New Haven Connecticut 06511 United States Details
Hackensack University Medical Center NOT_YET_RECRUITING Hackensack New Jersey 07601 United States Details
New York University Langone Medical Center NOT_YET_RECRUITING New York New York 10016 United States Details
SCRI Oncology Partners NOT_YET_RECRUITING Nashville Tennessee 37203 United States Details
National Cancer Center Hospital East NOT_YET_RECRUITING Chiba, Kashiwa 277-8577 Japan Details
National Cancer Center Hospital RECRUITING Tokyo, Chuo-ku 104-0045 Japan Details
Hospital Universitari Vall d'Hebron NOT_YET_RECRUITING Barcelona 08035 Spain Details
Clínica Universidad de Navarra NOT_YET_RECRUITING Pamplona 31008 Spain Details
Hospital Clinico Universitario de Valencia RECRUITING Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field